首页 > 市场调查报告书 > 製药

神经疾病

市场调查报告书

商品编码

1573693

远端癫痫市场、机会、成长动力、产业趋势分析与预测，2024-2032

Tele-epilepsy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月26日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年全球远程癫痫市场价值为 4.081 亿美元，预计 2024 年至 2032 年复合年增长率为 15.9%。

对远距医疗的认识和接受度的提高，加上政府的支持性政策和有利的报销框架，将加速远距癫痫服务的采用。值得注意的是，医疗保险和医疗补助服务中心(CMS) 强调，在过去五年中，包括癫痫在内的慢性疾病的远距医疗就诊次数大幅增加了64%，这凸显了人们对远距医疗保健的日益依赖。

随着远距医疗解决方案的需求加剧，老年人口数量不断增加，更容易患癫痫，加上癫痫病例普遍增加，将推动市场成长。世界卫生组织 (WHO) 于 2023 年报告称，全球约有 5,000 万人患有癫痫症，其中很大一部分是老年人。这种广泛的盛行率凸显了持续监测和管理的必要性，并强调了先进的远端癫痫技术在确保有效护理方面的关键作用。

整个产业分为成分、癫痫类型、年龄层、最终用户和地区。

该市场按组件细分，包括软体、服务和硬体。软体领域占据市场主导地位，预计在预测期内复合年增长率为 16.2%。在软体类别中，基于云端的解决方案和本地解决方案之间存在差异。该软体的市场主导地位源于其在远端监测和癫痫管理方面的关键功能，为利害关係人提供了资料收集和患者参与的基本工具。这些软体解决方案有助于即时脑电图监测、资料分析和远端会诊，以确保持续的患者护理、及时的干预和客製化的治疗计划，从而提高癫痫管理的有效性。

按癫痫类型细分，远程癫痫市场包括局部癫痫发作、全身性癫痫发作和组合性癫痫发作类别。 2023 年，由于癫痫发作的高发病率和复杂的管理需求，全身性癫痫细分市场以 59.7% 的份额引领市场。鑑于全身性癫痫发作同时影响两个大脑半球，通常需要持续监测和定期治疗调整。

2023 年美国远程癫痫市场价值为 2.187 亿美元，预计到 2032 年底将飙升至 7.955 亿美元。美国的优势在于其成熟的医疗基础设施和远距医疗技术的广泛采用，从远距诊断到远距咨询平台。此外，支持性的政府倡议、优惠的报销政策和不断的技术进步进一步巩固了美国在远程癫痫市场的主导地位。

产业生态系统分析
产业影响力
- 成长动力
  - 癫痫盛行率上升
  - 远端监控服务需求不断成长
  - 远距医疗服务的技术进步
  - 患者和照护人员的意识不断提高
- 产业陷阱与挑战
  - 资料安全和隐私问题
成长潜力分析
未来市场趋势
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按组成部分，2021 - 2032 年

主要趋势
软体
- 基于云端
- 本地
服务
- 电话咨询服务
- 远端监控和筛检服务
- 远距教育和培训
- 其他服务
硬体

第 6 章：市场估计与预测：按癫痫类型，2021 - 2032 年

主要趋势
局部性癫痫发作
全身性癫痫发作
合併癫痫发作

第 7 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
儿科
成年人

第 8 章：市场估计与预测：按最终用户，2021 - 2032 年

主要趋势
医疗保健提供者
- Hospitals and clinics
- Specialized epilepsy centers
- Homecare settings
患者
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Bioserenity SAS
Ceribell, Inc.
CortiCare, Inc.
Epitel, Inc.
Empatica Inc.
MedaSync.
Medtronic plc
NeuroPace, Inc.
Ovation Healthcare
Real Time Tele-Epilepsy Consultants.
ScienceSoft USA Corporation
Seer Medical
Teladoc Health, Inc.
UCB S.A.
Vidyo, Inc.

简介目录

Product Code: 11022

The Global Tele-Epilepsy Market was valued at USD 408.1 million in 2023 and is projected to grow at a CAGR of 15.9% from 2024 to 2032. This growth is primarily driven by the rising prevalence of epilepsy and an increasing demand for remote management solutions.

Heightened awareness and acceptance of telehealth, along with supportive government policies and favorable reimbursement frameworks, are set to accelerate the adoption of tele-epilepsy services. Notably, the Centers for Medicare and Medicaid Services (CMS) highlighted a significant 64% surge in telehealth visits for chronic conditions, including epilepsy, over the last five years, underscoring the growing reliance on remote healthcare.

The expanding elderly demographic, more prone to epilepsy, combined with a general uptick in epilepsy cases, is poised to drive market growth as the demand for remote healthcare solutions intensifies. The World Health Organization (WHO) reported in 2023 that around 50 million people globally are affected by epilepsy, with a notable portion being elderly. This widespread prevalence accentuates the necessity for ongoing monitoring and management, underscoring the pivotal role of advanced tele-epilepsy technologies in ensuring effective care.

The overall industry is divided into component, epilepsy type, age group, end-user, and region.

The market, segmented by component, includes software, services, and hardware. Dominating the market, the software segment is projected to grow at a CAGR of 16.2% during the forecast period. Within the software category, there is a distinction between cloud-based and on-premises solutions. The software's market dominance stems from its crucial function in remote monitoring and epilepsy management, equipping stakeholders with essential tools for data collection and patient engagement. These software solutions facilitate real-time EEG monitoring, data analysis, and teleconsultations for ensuring continuous patient care, timely interventions, and tailored treatment plans that bolster the effectiveness of epilepsy management.

Segmented by epilepsy type, the tele-epilepsy market includes focal seizure, generalized seizure, and combined seizure categories. In 2023, the generalized seizure segment led the market with a 59.7% share, driven by the high prevalence and intricate management needs of these seizures. Given that generalized seizures impact both brain hemispheres simultaneously, they often necessitate continuous monitoring and regular treatment adjustments.

U.S. tele-epilepsy market was valued at USD 218.7 million in 2023 and is projected to soar to USD 795.5 million by the end of 2032. This robust growth is attributed to the high prevalence of epilepsy in the U.S., driving demand for advanced management solutions. The U.S. advantage lies in its established healthcare infrastructure and the widespread embrace of telehealth technologies, from remote diagnostics to teleconsultation platforms. Moreover, supportive government initiatives, favorable reimbursement policies, and relentless technological advancements further cement the U.S.'s dominant position in the tele-epilepsy market.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of epilepsy
  - 3.2.1.2 Growing demand for remote monitoring services
  - 3.2.1.3 Technological advancement in telehealth services
  - 3.2.1.4 Rising awareness among patients and caregivers
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Data security and privacy concerns
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
- 5.2.1 Cloud-based
- 5.2.2 On-premises
5.3 Services
- 5.3.1 Tele-consultation services
- 5.3.2 Tele-monitoring and screening services
- 5.3.3 Tele-education and training
- 5.3.4 Other services
5.4 Hardware

Chapter 6 Market Estimates and Forecast, By Epilepsy Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Focal seizure
6.3 Generalized seizure
6.4 Combined seizure

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pediatrics
7.3 Adults

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Healthcare providers
- 8.2.1 Hospitals and clinics
- 8.2.2 Specialized epilepsy centers
- 8.2.3 Homecare settings
8.3 Patients
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa